Apatinib With Ifosfamide Plus Etoposide for Relapsed or Refractory Osteosarcoma (OAIE)

NCT05277480 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

81

Enrollment

OTHER

Sponsor class

Conditions

Effect of Drug
Drug
Toxicity

Interventions

DRUG: Apatinib+IE
DRUG: IE

Sponsor

Peking University People's Hospital

Collaborators

[object Object]